- Home
- GIPR vs NBY Comparison
GIPR vs NBY Comparison
Compare GIPR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIPR
- NBY
- Stock Information
- Founded
- GIPR 2015
- NBY 2000
- Country
- GIPR United States
- NBY United States
- Employees
- GIPR N/A
- NBY N/A
- Industry
- GIPR Real Estate Investment Trusts
- NBY
- Sector
- GIPR Real Estate
- NBY
- Exchange
- GIPR Nasdaq
- NBY Nasdaq
- Market Cap
- GIPR 6.4M
- NBY 6.3M
- IPO Year
- GIPR 2021
- NBY 2007
- Fundamental
- Price
- GIPR $1.34
- NBY $1.20
- Analyst Decision
- GIPR
- NBY Strong Buy
- Analyst Count
- GIPR 0
- NBY 1
- Target Price
- GIPR N/A
- NBY $0.85
- AVG Volume (30 Days)
- GIPR 1.2M
- NBY 466.6K
- Earning Date
- GIPR 11-14-2025
- NBY 11-10-2025
- Dividend Yield
- GIPR N/A
- NBY N/A
- EPS Growth
- GIPR N/A
- NBY N/A
- EPS
- GIPR N/A
- NBY 0.41
- Revenue
- GIPR $9,884,093.00
- NBY $9,781,000.00
- Revenue This Year
- GIPR $1.12
- NBY $23.91
- Revenue Next Year
- GIPR $0.52
- NBY $32.05
- P/E Ratio
- GIPR N/A
- NBY $3.11
- Revenue Growth
- GIPR 2.33
- NBY 113.47
- 52 Week Low
- GIPR $0.78
- NBY $0.46
- 52 Week High
- GIPR $2.14
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- GIPR 49.08
- NBY 45.80
- Support Level
- GIPR $1.18
- NBY $1.17
- Resistance Level
- GIPR $1.88
- NBY $1.31
- Average True Range (ATR)
- GIPR 0.23
- NBY 0.15
- MACD
- GIPR -0.02
- NBY 0.02
- Stochastic Oscillator
- GIPR 22.62
- NBY 49.43
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.